Decrease of peripheral blood lymphocyte count predicts response to neoadjuvant chemotherapy in breast cancer patients

PURPOSE: Pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) holds promise as a significant prognostic factor to predict NAC response in breast cancer patients. The absolute peripheral blood lymphocyte (PBL) count has been suggested as an independent predictor of response to NAC....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ok Hee, Min, Sun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Surgical Oncology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942727/
https://www.ncbi.nlm.nih.gov/pubmed/36945713
http://dx.doi.org/10.14216/kjco.20013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942727/
https://www.ncbi.nlm.nih.gov/pubmed/36945713
http://dx.doi.org/10.14216/kjco.20013

Ejemplares similares